These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 473414

  • 41. Effects of prostaglandin E1 infusion in the pre-operative management of critical congenital heart disease.
    Ohara T, Ogata H, Fujiyama J, Murata Y, Abe J, Kakuta K, Hayamizu S, Kameyama S, Yoshida Y.
    Tohoku J Exp Med; 1985 Jun; 146(2):237-49. PubMed ID: 4040664
    [Abstract] [Full Text] [Related]

  • 42. Indications and pharmacological effects of therapy with prostaglandin E1 in the newborn.
    Schöber JG, Kellner M, Mocellin R, Schumacher G, Bühlmeyer K.
    Adv Prostaglandin Thromboxane Res; 1980 Jun; 7():905-11. PubMed ID: 7369055
    [No Abstract] [Full Text] [Related]

  • 43. Prostaglandins and the ductus arteriosus.
    Olley PM, Coceani F.
    Annu Rev Med; 1981 Jun; 32():375-85. PubMed ID: 7013675
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Medical treatment of ductus arteriosus.
    Ivey HH, Wells HH, Kattwinkel J.
    Pediatrics; 1980 Apr; 65(4):863. PubMed ID: 7367106
    [No Abstract] [Full Text] [Related]

  • 47. [Perfusion with prostaglandins (PGE) in newborn infants with acute cardiopathy].
    Moreno F, Burgueros M, Herraiz I, Quero C, Sánchez PA, Omeñaca F, Martínez A.
    Rev Esp Cardiol; 1978 Apr; 31(3):335-8. PubMed ID: 674795
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Bone formation induced in an infant by systemic prostaglandin-E2 administration.
    Jørgensen HR, Svanholm H, Høst A.
    Acta Orthop Scand; 1988 Aug; 59(4):464-6. PubMed ID: 3166573
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Effect of prostaglandins and some methyl derivatives on the ductus arteriosus.
    Starling MB, Neutze JM, Elliott RB.
    Adv Prostaglandin Thromboxane Res; 1978 Aug; 4():335-43. PubMed ID: 206122
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Effect of E1 type prostaglandin on hypoxemia in a cyanotic congenital cardiac malformation.
    Moulaert A, Senders R, van Ertbruggen I, Huysmans H, Harinck E.
    Eur J Cardiol; 1977 Jun; 5(4):321-5. PubMed ID: 891577
    [Abstract] [Full Text] [Related]

  • 56. Pharmacologic maintenance of the ductus arteriosus.
    Freed MD.
    Conn Med; 1982 Mar; 46(3):131-4. PubMed ID: 7075183
    [No Abstract] [Full Text] [Related]

  • 57. Administration of prostaglandin E1 in neonates with critical congenital cardiac defects.
    Lewis AB, Takahashi M, Lurie PR.
    J Pediatr; 1978 Sep; 93(3):481-5. PubMed ID: 690772
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.